Sofosbuvir, with the CAS number 1190307 - 88 - 0, is a revolutionary antiviral drug in the field of hepatitis C treatment. Our product is factory - supplied, ensuring high - quality and best - price offers for customers.
Basic Information and Parameters:
Sofosbuvir is mainly used for the treatment of hepatitis C virus (HCV) infections. It is a nucleotide analog inhibitor of the HCV NS5B polymerase, which plays a key role in the replication of the virus. By inhibiting this polymerase, sofosbuvir can effectively block the replication process of HCV, thereby reducing the viral load in the patient's body.
It can be used in combination with other antiviral drugs to form a comprehensive treatment regimen, which can significantly improve the cure rate of hepatitis C. This product is suitable for different genotypes of HCV - infected patients, providing a more extensive treatment option for the clinical treatment of hepatitis C.
The usage of sofosbuvir should be strictly in accordance with the doctor's advice. Generally, it is taken orally. The recommended dosage is usually 400 mg once daily. It can be taken with or without food, but it is important to maintain a regular dosing schedule to ensure the stability of drug concentration in the body.
During the treatment process, patients need to regularly monitor their liver function, viral load and other indicators to evaluate the treatment effect. If any adverse reactions occur, such as nausea, fatigue, headache, etc., patients should inform their doctor in time, and the doctor will adjust the treatment plan according to the specific situation.
Case 1: Mr. Smith, a 45 - year - old male, was diagnosed with hepatitis C genotype 1. He started a treatment course with sofosbuvir in combination with ribavirin. After 12 weeks of treatment, his HCV RNA level dropped below the detectable limit, indicating a significant reduction in viral load. After 24 weeks of continuous treatment, he achieved a sustained virological response (SVR), which means that the hepatitis C virus was completely cleared from his body. His liver function also gradually returned to normal, and he no longer showed symptoms such as fatigue and jaundice.
Case 2: Ms. Johnson, a 38 - year - old female with hepatitis C genotype 3, received a treatment regimen of sofosbuvir and daclatasvir. She took sofosbuvir 400 mg once daily as prescribed. After 8 weeks of treatment, her HCV RNA level decreased significantly. By the end of the 16 - week treatment, she also achieved SVR. Her liver function improved, and she was able to return to her normal work and life.
If you have any questions about our Factory Supply Sofosbuvir Cas 1190307 - 88 - 0, please feel free to contact us.
This is William, CEO of Zhishang Chemical Co., Ltd.
Welcome to visit our factory . As the top chemical manufacturer, we have been striving for product quality, innovation , R&D, and customer service for the past 7 years. In the next 10 years or even longer, we are committed to becoming the most reliable chemical supplier in the world , creating a well-known international brand trusted by customers, with the spirit of “one meter wide, ten thousand meters deep”, we continue to focus on product research and development, continue to focus on customer service, continue to improve the supply chain service system, to create a professional chemical supply service team, to achieve win-win long-term cooperation. Please feel free to contact us if you have any questions.
English (United States) 
English (Australia) 
Portuguese 
Spanish